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Abstract:
Introduction:
Bioactive-glass (B-G) has become a valuable adjunct to promote hard-tissue healing in many clinical situations and is of particular
interest  for  endodontic  care  because  of  its  biocompatibility,  regenerative  and  antimicrobial  properties  as  well  as  chemical
composition  that  closely  resembles  the  mineral  make-up  of  human  bone  and  dentine.
Therapy:
Initial studies suggested that bacteria-tight sealing within the entire root canal system can be achieved and successfully maintained
after orthograde treatment. Promising results have also been obtained in conjunction with microsurgical techniques, with the aim of
enhancing wound healing and positively influencing bone regeneration.
Conclusion:
Here, relevant literature was explored to present a comprehensive review of the rationale, development, and current applications of
B-G in Endodontology illustrating them with case reports.
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INTRODUCTION
The utilization of biomaterials is an established feature in Dentistry and their importance is readily acknowledged.
Research in Endodontology often involves proven materials that have been thoroughly tested by scientific investigation
and  clinical  usage,  as  well  as  others  that  are  the  result  of  new  knowledge  and  expectation  to  improve  treatment
outcomes in terms of percentages of success. Bioactive-glass (B-G, henceforth used in the text for brevity) has become
a valuable adjunct to promote hard-tissue healing in many situations [1 - 3] and is of particular interest for endodontic
care  because  its  chemical  composition  (silicium,  sodium,  calcium  and  phosphorus  oxides  with  specific  weight
percentages)  closely  resembles  the  mineral  make-up  of  human  bone  and  dentine.  Considering  the  excellent
biocompatibility, regenerative and antimicrobial properties of this material and the fact that it has been in use for more
than forty years [4], its range of dental applications is still small. The goal of this investigation was to evaluate the use
of  B-G  in  endodontic  therapy  and  associated  microsurgery,  and  provide  clinical  findings.  Clinical  records  and
radiographic images were collected from patients who had undergone root canal treatment or periradicular surgery in
private practice and had a minimum 1-year follow-up, which was deemed sufficient in predicting healing after surgery
[5]. As part of the review process, original articles published in English from 1971 (year of B-G being introduced) [4]
up to, and including, 21st August 2016 were considered for the discussion of its advantages in terms of efficacy and
efficiency. The search of bibliographical databases including  medline  (pubmed),  web  of  science,  scopus,  scielo  and
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cochrane was performed by using keywords as well as MeSH terms in addition to selective hand-searching of citations
contained within located articles. The biochemical and cellular mechanisms of action and the role that they play in the
healing process were also elucidated.
ORTHOGRADE ROOT CANAL THERAPY
Obturation materials should form a bacteria-tight seal within the entire root canal system [6]. Therefore, they must
ensure impervious sealing throughout long periods and should be volumetrically stable (or expand slightly).  Gutta-
percha,  introduced  as  exclusive  material  in  endodontic  therapy  [7],  is  thermoplastic  and  hence  can  be  warmed  to
improve its  adaptation  to  the  complex root  canal  anatomy.  It  must  be  emphasized  that  heated  gutta-percha  shrinks
considerably upon cooling to body temperature [8]. To compensate for this shrinkage, elaborate application techniques
and  a  canal  wall  lining  material,  that  is  a  sealer,  have  been  adopted  [9].  Sealers  are  not  necessarily  bioinert  when
extruded  beyond  the  apex  and  in  contact  with  periapical  bone  [10].  Furthermore,  sealers  may  adhere  with  varying
strength to gutta-percha and the root canal wall, resulting in interfacial gaps, microchannels, porosities and thus coronal-
apical leakage. Calcium silicate-based cements have gained wide acceptance in the endodontic community to fill teeth
with open apices, for perforation repair and as root-end filling materials, owing to their good physico-chemical and
biological properties [11]. It is known that they adhere to hydrated dentinal walls by forming a crystalline bond via a
diffusion-controlled process, a feature also reported for a restricted group of synthetic, commercially available bone
substitutes, usually surface reactive glass-ceramics. Among these is B-G (grade 45S5, US Biomaterials Co., Alachua,
FL,  USA),  the  first  man-made  material  to  bond  to  bone  [4],  that  is  based  on  a  simple  four-component  system  of
minerals normally found in the skeleton and teeth such as silica [SiO2 (46.1 wt.%)], sodium oxide [Na2O (24.4 wt.%)],
calcium oxide [CaO (26.9 wt.%)],  and phosphorus pentoxide [P2O5  (2.6 wt.%)].  B-G has been successfully used in
dentine remineralization procedures [12] due to its ability to dissolve, upon contact with physiological body fluids or
human plasma, and promote mineral precipitation with subsequent crystallization of hydroxyl carbonate apatite (HCA)
on the glass/tissue interface.  The detailed analysis  of  the reactions involved has  been presented by Hench [4].  The
process involves five stages which occur very rapidly on the surface of B-G particles because of fast ion exchange of
alkali ions with hydrogen ions from the liquid medium (stage 1), glass network dissolution (stage 2), condensation of a
silica-rich mass (stage 3),  and calcium phosphate precipitation followed by crystallisation of the HCA layer within
hours (stages 4 and 5). Such a phase is chemically and structurally similar to the mineral phase of human bone and
dentine,  allowing  accelerated  interfacial  fusion  and  consolidation  without  toxicological  consequences  [12].
Unfortunately,  root  canals  filled  solely  with  a  calcium  silicate-based  cement  can  never  be  retreated,  a  corrective
measure  that  is  deemed  important  by  most  clinicians.  For  this  reason  it  was  suggested  to  incorporate  crystallizing
particles into matrix polymers of core root filling materials. The premise was that the formation of calcium phosphate
precipitates  on  the  material’s  surface  under  moist  conditions,  once  accomplished,  should  render  the  conventional
restoration more adhesive in root canals, which are inherently wet [7, 13]. In an initial study, incorporation of B-G into
polyisoprene,  the  matrix  polymer  of  gutta-percha,  proved  to  enhance  the  dentinal  sealing  due  to  the  compound’s
hydrophilic properties and the resultant moisture expansion towards the canal wall [14]. This effect was fully described
in a work by Mohn et al. [15] and appeared to happen immediately when ultrafine bioactive contents of up to 30 wt%
had been incorporated into the gutta-percha matrix. Similarly, Resilon™ (Pentron® Clinical Technologies, Wallingford,
CT, USA) and its accompanying dual-cure methacrylic primer/sealer Epiphany™ (Pentron® Clinical Technologies),
also  sold  as  RealSeal  (SybronEndo,  Orange,  CA,  USA),  were  introduced  after  fundamental  research  based  on
developing  a  bioactive  obturation  system that  would  fuse  to  dentine  and  form a  monoblock  within  the  canal  [16].
According to Shanahan and colleagues [17], a strategic advantage was that, even in the absence of coronal restoration,
leakage could be eliminated or dramatically reduced. The authors also suggested that this monoblock would be highly
beneficial in order to strengthen the structure of the tooth attenuated by endodontic instrumentation. While this might be
considered a secondary benefit as compared to its potential to ensure a thorough seal of the root canal system, it is not in
any  way  inconsequential  considering  that  gutta-percha  does  not  reinforce  weakened  roots.  To  be  used  with  any
conventional obturation technique, Resilon™ points were developed in different tapers and ISO sizes from the synthetic
polymer polycaprolactone, which is a thermoplastic aliphatic polyester, filled with radiopaque particles as well as B-G
to impart bioactivity [17]. Use of a self-etch primer was advocated to improve adhesion of obturation core, sealer and
dentine to one another, while simultaneously taking advantage of B-G’s unique characteristics: potential to displace
water from the underfilled regions of the root canal system, redeposition of apatitic tooth mineral and formation of a
physical bond with the moist dentine surface [7]. It was postulated that moisture would not eventually affect the initial
micromechanical interlocking established by the hydrophilic primer/sealer components into open dentinal tubules, but
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actually help to drive crystallization reactions within and around the core material [14]. As this process can bind water
over long periods of time and encourage reprecipitation of apatitic deposits, it was anticipated that it might contribute to
limit bacterial leakage during long-term function [16]. Since its introduction, a number of reports have been published
regarding various aspects of Resilon™ system which would offer an improvement over gutta-percha. Different studies
provided  preliminary  evidence  that  when  teeth  were  treated  with  Resilon™,  the  leakage  behavior  was  an  order  of
magnitude less than that found with conventional obturation materials and methods [17]. Healing rates for Resilon™-
filled  teeth  in  private  practice  Fig.  (1)  have  been  reported  to  be  within  the  range  of  success  rates  for  studies  with
treatment techniques mostly in university settings with gutta-percha root filling [18]. However, these preliminary results
require more profound analysis,  longer follow-up periods and a larger number of patients to tell  if  the inclusion of
highly reactive silicate compounds, such as B-G, within the composition of root canal filling materials might prove an
evidence-based replacement for gutta-percha which has an established research track record over many years.
Fig. (1). Periapical x-rays before and after root canal treatments. (a) Preoperative radiograph of upper left first molar (26); (b) One-
year follow up radiograph of 26 obturated with vertically condensed gutta-percha and an epoxy-resin sealer; (c) Lower left first molar
(36)  before  root  canal  treatment;  (d)  One-year  follow  up  radiograph  of  36  obturated  with  vertically  condensed  Resilon™ and
RealSeal™ sealer. Note the similar radiopacity of the two filling materials (b and d).
ENDODONTIC MICROSURGERY
The success rates of conventional endodontic therapy have been improving over the years, although persistence of
pathologic periapical conditions is far from a rare condition [19]. This fact suggests a considerable need for further
treatment. Endodontic microsurgery is indicated when an orthograde approach is not possible or has not yielded the
desired  healing  outcome,  and  to  secure  a  biopsy.  The  most  common  endodontic  surgical  procedure  consists  of
periradicular curettage, root-end resection, preparation and filling with the help of an operating microscope. Different
materials have been used to seal the canal system apically and prevent the egress of bacteria and their by-products into
the surrounding tissues with varying results [20 - 22]. Surveys such as that conducted by Maltezos et al. [22] showed
that an ideal retrofilling material should have the following properties: besides good adherence to the dentine, it should
be easy to use clinically, biocompatible, and dimensionally stable over time. Clinically high, long-term success rates
(84-92%) were reported for MTA® cement (ProRoot; Dentsply Tulsa Dental Specialties, Tulsa, OK), a derivative of a
type I ordinary Portland cement with 4:1 proportions of bismuth oxide added for radiopacity [23]. Likewise, clinical
studies showed enhanced success over long periods with Super EBA™ (Bosworth Company, Skokie, IL), a zinc oxide-
eugenol  cement  modified  with  ethoxybenzoic  acid  [24].  Several  bone  replacement  materials  were  placed  in  the
periradicular surgical cavities in the attempt to enhance bony healing. Reviewing the literature provided some studies
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that showed increased radiographic success consequent on grafting, particularly with large lesions (over 10 mm) [25].
Most  materials,  at  best,  elicit  a  neutral  response  when  implanted  into  the  human  body.  B-G  however  was  seen  to
dissolve at a rate equal to that at which new host tissue is remodelled, serving as a biocompatible framework along
which mesenchymal stem cells migrate due to its excellent osteoconductive ability [3]. As mentioned in the previous
section, the mechanism of gradual dissolution of the glass matrix, concomitant with synthesis of new hard tissue on its
surface, presupposes an initial exchange of ions and results in a build-up of HCA that is of the same composition as the
normal mineral phase of bone [4]. B-G has also been reported to be osteoinductive, encouraging osteogenic precursors
to  proliferate  and  differentiate  into  matrix-producing  osteoblasts  Fig.  (2).  Entire  classes  of  genes  associated  with
osteoblast growth and differentiation, maintenance of extracellular matrix, as well as promotion of cell-cell and cell-
matrix adhesion, are up-regulated by the dissolution products of B-G [26]. Moreover, the controlled release of soluble
ionic species promotes recruitment of mucopolysaccharides and glycoproteins from adjacent tissues into an organic
matrix rich of collagen fibers in intimate contact with newly formed crystals of HCA, facilitating bone regeneration
uniformly  throughout  the  defect.  Readers  should  be  aware  that  similar  cellular  events  do  not  occur  with  any  other
material because of the lack of similar ionic stimuli [4]. In vitro studies have found that dissolution of ionic species also
leads  to  an  increase  of  the  local  pH  at  values  between  11.4  and  11.8,  which  is  strongly  antibacterial  [7]  and  thus
particularly  beneficial  for  dead  space  management  of  areas  that  are  chronically  infected.  As  often  reported  in  the
literature, B-G may have a barrier function that hinders faster-growing connective tissue from penetrating the bone
cavity [27]. Since its introduction, the original B-G has been released as PerioGlas® (now sold by NovaBone Products
LLC,  Alachua,  FL,  USA)  demonstrating  consistent  results  in  a  variety  of  bone  regenerative  treatments  [3].  In
periodontal  surgical  procedures,  it  has  been  used  to  stimulate  bone  regeneration,  primarily  in  the  treatment  of
interproximal bone defects [2]. This resulted in a 50-70% size reduction of bone cavities [28]. Radiographic evaluations
conducted after osseous fill with PerioGlas ® during endodontic surgery showed earlier bone regeneration Fig. (3) and a
higher  rate  of  success  compared  to  merely  sealing  the  apical  part  of  the  tooth  [27].  Moreover,  PerioGlas®  had  a
hemostatic effect after being applied to the spongiosa, as illustrated in other studies [3].
Fig. (2). Timeline of molecular and cellular B-G reactions (modified after reference [4]). The process starts with five inorganic stages
that occur very rapidly on the surface of B-G particles and lead to formation of polycrystalline HCA. The latter fastens down rapidly
with the surrounding tissue from step 6 and acts as framework for the ingrowth of new bone. 3D architecture of mineralized bone is
created  by  mesenchymal  stem  cells  in  response  to  critical  concentrations  of  the  soluble  ionic  constituents  released  from  B-G.
Mineralization of the matrix follows thereafter and mature osteocytes, encased in a collagen-HCA matrix, are the final product by 6-8
days in vitro and in vivo.
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Fig. (3). Clinical application of B-G during endodontic surgery. (a) Intraradicular post protruding through a perforation is noted
radiographically; (b) Post reduction followed by root repair; (c) B-G placed into the surgical crypt prior to closure; (d) At one-year
follow-up,  resolution  of  furcal  radiolucency;  (e)  Preoperative  radiological  situation;  (f)  Completed  root-end  filling;  (g)  B-G
embedded  in  the  bone  cavity;  (h)  Resolution  of  radiolucency  and  reattachment  of  periodontal  ligament  at  one-year  control;  (i)
Preoperative periapical x-ray; (j) Retrofilling placed; (k) Immediate post-operative x-ray following apicoectomy with concomitant B-
G grafting;  (l)  One-year  follow up radiograph shows complete  healing;  (m)  Preoperative  periapical  radiograph;  (n)  Terminated
retrograde filling; (o) Intraoperative image showing B-G in place to fill in the bony cavity; (p) Radiological situation one year after
surgery representing complete resolution of the periapical lesion.
CONCLUSION
The arena of dental materials science is continuing to evolve and, in fact, a new day has dawned. This new horizon
is the increased use of silicate compounds, including B-G, either as filler materials/coatings for polymer structures or as
synthetic bone graft substitutes to elicit specific biological responses. Information on treatment outcomes is essential for
the  decision-making  process.  We  must  adopt  stricter  controls  and  performance  standards,  particularly  with  the
evaluation of new products and technologies, for generating robust data in clinical studies and reaching our goal to
implement highest standards of endodontics. Thus, understanding the science, technology and properties of B-G is a
very important need for the oral healthcare community. This is a field of intense research, which is clearly manifested in
the increasing number of publications with regard to its clinical applications [2, 12]. A number of authors listed the
many benefits of this material in endodontic therapy [7, 14, 15] and associated microsurgery [27]. B-G’s ingenious
moisture-initiated setting reaction, concomitant with the notable in situ nucleation of HCA and its precursors to form a
mineral  matrix,  as  well  as  the  ability  to  enhance  osteoblast  adhesion,  revascularization  and  differentiation  of
mesenchymal  stem cells,  undoubtedly  represents  a  major  step  forward  on  the  path  to  ultimate  endodontic  success.
Furthermore, the unique bacterial growth inhibiting feature of B-G granules gives distinct advantages in areas that are
postoperatively  prone  to  infection,  contributing  to  the  resolution  of  inflammatory  responses  and  providing
extraordinarily  favourable  conditions  for  an  uneventful  healing  process.  Present  experience  with  B-G supports  the
convenience of this biomaterial for the elimination of osseous defects due to periradicular pathologies and surgeries
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over alternate forms of synthetic graft materials. The initial evaluation of biologically active silicate compounds as a
possible addition to the root canal space obturation process has also shown its value; further studies as a part of head to
head comparisons with traditional materials are necessary to confirm these preliminary findings.
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